Streetbeat News

Stock Prices

CRI

Carter's (NYSE:CRI) received mixed ratings from 4 analysts, with a shift towards a more neutral stance in the last 30 days. The average 12-month price target is $75.75, indicating a 10.99% increase from the previous target. Analysts from UBS, Evercore ISI Group, Wedbush, and Citigroup adjusted their price targets, reflecting changes in market conditions and company performance. Despite a -3.29% decline in revenue over the past 3 months, Carter's demonstrates strong financial health with an 8.19% net margin and an 8.31% ROE. The company's debt-to-equity ratio is below industry average, suggesting conservative financial management.

Portfolio Pulse from Benzinga Insights

February 28, 2024 | 7:01 pm

SOUN

SoundHound AI (NASDAQ:SOUN) is expected to report its quarterly earnings with an estimated EPS of $-0.06 on Thursday, 2024-02-29. Analysts and investors are looking for an earnings beat and positive guidance for the next quarter. Historically, SoundHound AI's share price has reacted to both its earnings performance and the guidance provided. Last quarter, the company met its EPS estimate, resulting in a 3.47% share price increase the following day. Over the last year, SOUN shares have surged by 149.01%, indicating a bullish sentiment among long-term shareholders.

Portfolio Pulse from Benzinga Insights

February 28, 2024 | 7:00 pm

DNLI

Four analysts have recently updated their ratings on Denali Therapeutics (NASDAQ:DNLI), showing a mix of bullish and somewhat bullish perspectives. The average 12-month price target is now $65.75, a significant decrease from the previous $105.00. Analyst actions include lowering and maintaining ratings, with price targets ranging from $31.00 to $95.00. Denali Therapeutics, a biotech company focused on neurodegeneration diseases, has seen a -64.4% decline in revenue growth and faces financial health challenges, including a net margin of -7841.59% and an ROE of -8.62%.

Portfolio Pulse from Benzinga Insights

February 28, 2024 | 7:00 pm

HES

Hess Corporation (NYSE:HES) has delivered an impressive average annual return of 19.72% over the past 5 years, outperforming the market by 7.05% annually. An investment of $1000 in HES five years ago would be worth $2,451.54 today, showcasing the significant impact of compounded returns on investment growth. Hess currently has a market capitalization of $44.47 billion.

Portfolio Pulse from Benzinga Insights

February 28, 2024 | 7:00 pm

KFY

Analyst ratings for Korn Ferry (NYSE:KFY) show mixed sentiments with 1 bullish and 3 indifferent ratings. The average 12-month price target is $57.5, reflecting a 1.77% increase from the previous target. Korn Ferry's financial performance indicates challenges, with a revenue decline of -3.16% and below-average profitability metrics. Analysts' actions and price target adjustments highlight their response to market conditions and company performance.

Portfolio Pulse from Benzinga Insights

February 28, 2024 | 7:00 pm

HUM

Over the past 10 years, Humana (NYSE:HUM) has delivered an average annual return of 12.09%, outperforming the market by 1.64% annually. A $1000 investment in HUM a decade ago would be worth $3,133.80 today. Humana's market capitalization currently stands at $43.65 billion.

Portfolio Pulse from Benzinga Insights

February 28, 2024 | 7:00 pm

AMBA

Ambarella (NASDAQ:AMBA) has received mixed reviews from 9 analysts, with recent ratings ranging from bullish to bearish. The average 12-month price target is $78.33, marking a 12.87% increase from the previous target of $69.40. Analyst actions include maintaining, raising, and lowering ratings and price targets, reflecting varied perspectives on the company's performance and market dynamics. Ambarella's financials show challenges in revenue growth, net margin, ROE, and ROA, but a low debt-to-equity ratio suggests conservative financial management.

Portfolio Pulse from Benzinga Insights

February 28, 2024 | 7:00 pm

PENN

Recent analyst ratings for PENN Entertainment (NASDAQ:PENN) show a diverse range of perspectives, with a notable decline in the average 12-month price target to $27.5, down 5.17% from the previous average. Analysts from firms including Morgan Stanley, Stifel, Truist Securities, Macquarie, and Needham have adjusted their ratings and price targets, reflecting changing market conditions and company performance. PENN's financial indicators suggest challenges in revenue growth, profitability, and asset utilization, with a revenue decline of -12.0% as of December 31, 2023, and below-industry benchmarks in net margin and ROE.

Portfolio Pulse from Benzinga Insights

February 28, 2024 | 7:00 pm

MATICUSD

Polygon (CRYPTO: MATIC) experienced a 3.91% price drop in the last 24 hours, falling to $0.99, despite a 10% gain over the past week. The trading volume has remained stable, while the circulating supply increased by 0.28% to 9.28 billion, representing 92.83% of its max supply. MATIC's market cap ranking is currently #16 at $9.18 billion.

Portfolio Pulse from Benzinga Insights

February 28, 2024 | 7:00 pm

AGO

Assured Guaranty shares are trading higher following the announcement of their Q4 financial results.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 6:54 pm